The present invention is directed to novel compounds. These compounds can be useful in inhibiting the activity of protein prenyltransferases including GGTase I and/or RabGGTase. The compounds can also be used as anti-cancer therapeutics including as part of methods for treating cancer, in assays, and in kits.
US8017607B2
申请人:——
公开号:US8017607B2
公开(公告)日:2011-09-13
US8815935B2
申请人:——
公开号:US8815935B2
公开(公告)日:2014-08-26
[EN] NOVEL N-SUBSTITUTED-PYRROLIDINES AS INHIBITORS OF MDM2-P-53 INTERACTIONS<br/>[FR] NOUVELLES PYRROLIDONES N-SUBSTITUÉES COMME INHIBITEURS D'INTERACTIONS MDM2-P53
申请人:HOFFMANN LA ROCHE
公开号:WO2011045257A1
公开(公告)日:2011-04-21
There are provided compounds of the formula (I) wherein X, Y, R1, R2, R3, R3, R4, and R5 are as described herein and enantiomers and pharmaceutically acceptable salts and esters thereof which are useful as anticancer agents.